Bivin & Associates’s Harrow HROW Stock Holding History

Bivin & Associates’s Portfolio HROW Stock Details HROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-115	Closed	-$1K	–	382
2021 Q4	$1K	Buy	+115	New	+$1.14K	﹤0.01%	317

Other funds holding HROW

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bivin & Associates's HROW Position: Q1 2022 in Review

Bivin & Associates sold out of Harrow (HROW) in Q1 2022, closing a stake of 115 shares — an estimated $1K sold.

Bivin & Associates first reported a position in HROW in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 80 funds tracked by Wall St. Rank hold HROW as of Q1 2022.

Bivin & Associates reported no remaining Harrow position as of Q1 2022 after selling out during the quarter.
Bivin & Associates sold 115 Harrow shares in Q1 2022, an estimated $1K.
Bivin & Associates first reported a position in Harrow in Q4 2021 and held it in 1 quarter.
Bivin & Associates's Harrow position peaked at $1K in Q4 2021.
80 funds tracked by Wall St. Rank held Harrow as of Q1 2022.

Based on Bivin & Associates's 13F filing for Q1 2022, filed 6 May 2022.